imipramine has been researched along with papaverine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (50.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Caron, G; Ermondi, G | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Sen, S; Sinha, N | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Farbiszewski, R; Niewiarowski, S; Poplawski, A | 1 |
| Bârzu, T; Brief, G; Csutak, W; Cuparencu, B; Steiner, L; Ticşa, I | 1 |
| Berndt, S; Ebert, R; Schwabe, U | 1 |
| Kocher, R; Rohrer, G | 1 |
| Spilker, BA; van Balken, H | 1 |
| Gordon, JL | 1 |
| Bounameaux, Y | 1 |
| Imamura, H; Maruyama, Y; Nakanishi, M | 1 |
| Bertazzoli, C; Bonsignori, A; Chieli, T; Pegrassi, L; Suchowsky, GK | 1 |
| Rosazza, JP; Smith, RV | 1 |
| Dawson, CA; Linehan, JH; Rickaby, DA | 1 |
| Halaska, M; Martan, A; Voigt, R | 1 |
| MARIANI, L | 1 |
| WASILEWSKA, L | 1 |
| Borka-Balás, R; Donáth-Nagy, G; Gáll, Z; Vancea, S | 1 |
1 review(s) available for imipramine and papaverine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for imipramine and papaverine
| Article | Year |
|---|---|
[Treatment of severe chronic pains with a combination of thymoleptics and neuroleptics (author's transl)].
Topics: Adult; Antidepressive Agents; Atropine; Chlorpromazine; Clinical Trials as Topic; Clomipramine; Drug Combinations; Female; Haloperidol; Humans; Imipramine; Male; Methotrimeprazine; Middle Aged; Morphine; Neoplasms; Pain; Papaverine; Tranquilizing Agents | 1974 |
26 other study(ies) available for imipramine and papaverine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)].
Topics: Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chloroquine; Citrates; Fibrinogen; Fibrinolysis; Heparin Antagonists; Imipramine; Ouabain; Papaverine; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Rabbits; Sodium Salicylate | 1969 |
[Pharmacological analysis of erythrocyte reaction to hypobarism].
Topics: Altitude; Amphetamine; Animals; Antidepressive Agents; Antihypertensive Agents; Atmospheric Pressure; Atropine; Benactyzine; Bone Marrow Examination; Bretylium Compounds; Dibenzylchlorethamine; Erythrocyte Count; Erythrocytes; Guanethidine; Hexamethonium Compounds; Imipramine; Mice; Nialamide; Papaverine; Reserpine; Reticulocytes | 1970 |
Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase.
Topics: Adipose Tissue; Animals; Binding Sites; Cattle; Cyclic AMP; Dipyridamole; Drug Antagonism; Imipramine; Lipid Metabolism; Male; Norepinephrine; Papaverine; Phosphoric Monoester Hydrolases; Phosphotransferases; Rats; Theophylline; Xanthines | 1972 |
Formation and embolization of thrombi after electrical stimulation. On the method and evaluation of drugs.
Topics: Animals; Aspirin; Cats; Cranial Sinuses; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Female; Guinea Pigs; Heparin; Imipramine; Male; Mesenteric Arteries; Mesenteric Veins; Methods; Mice; Papaverine; Phenoxybenzamine; Platelet Adhesiveness; Rabbits; Rats; Streptokinase; Thromboembolism; Time Factors | 1973 |
Differential changes in potency of platelet-aggregation inhibitors after preincubation in platelet-rich plasma.
Topics: Adenosine Diphosphate; Amitriptyline; Animals; Caffeine; Chlorpromazine; Diphenhydramine; Dipyridamole; Imipramine; Papaverine; Plasma; Platelet Adhesiveness; Swine; Time Factors; Trifluoperazine | 1974 |
[Pharmacodynamic prevention of thrombosis].
Topics: Adenosine Diphosphate; Amitriptyline; Anticoagulants; Aspirin; Collagen; Dipyridamole; Guanethidine; Humans; Imipramine; Papaverine; Thrombin; Thrombosis | 1971 |
[Studies on anti-inflammatory agents. II. Analgesic and anti-edematous activities of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6, 7-tetrahydrothieno (2,3-c)pyridine (Y-3642)].
Topics: Aminopyrine; Amphetamine; Analgesics; Animals; Anti-Inflammatory Agents; Edema; Imipramine; Male; Mice; Morphine; Pain; Papaverine; Phenylbutazone; Pyridines; Rats; Salicylates; Thiophenes | 1970 |
Some pharmacological properties of 4H-3-methylcarboxamide 1,3-benzoxazine-2-one (FI 6654).
Topics: Acetylcholine; Animals; Antidepressive Agents; Arousal; Atropine; Barium; Duodenum; Electroencephalography; Guinea Pigs; Histamine; Ileum; Imipramine; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Nicotine; Oxazines; Papaverine; Physostigmine; Rabbits; Rats; Seizures; Serotonin | 1969 |
Microbial models of mammalian metabolism.
Topics: Acronine; Animals; Apomorphine; Biotransformation; Dealkylation; Ellipticines; Ergolines; Guinea Pigs; Humans; Hydroxylation; Imipramine; Mammals; Models, Biological; Papaverine; Pharmaceutical Preparations | 1983 |
Influence of embolism and imipramine on kinetics of serotonin uptake by dog lung.
Topics: Animals; Capillary Permeability; Dogs; Dose-Response Relationship, Drug; Endothelium; Imipramine; Kinetics; Lung; Papaverine; Pulmonary Circulation; Pulmonary Embolism; Serotonin; Ventilation-Perfusion Ratio | 1984 |
[Drug therapy of urge incontinence in the female].
Topics: Adult; Aged; Diltiazem; Female; Humans; Imipramine; Middle Aged; Oxyphenonium; Papaverine; Parasympatholytics; Sulfonium Compounds; Urinary Incontinence, Stress; Urodynamics | 1993 |
[Drugs antagonistic to bradykinin].
Topics: Anti-Allergic Agents; Atropine; Bradykinin; Chlorpromazine; Ergotamine; Histamine H1 Antagonists; Imipramine; Lysergic Acid Diethylamide; Papaverine; Phenylbutazone; Promazine; Promethazine | 1961 |
[A NEW COMPLEXOMETRIC METHOD FOR THE DETERMINATION OF ORGANIC BASES].
Topics: Chemistry, Pharmaceutical; Chlorpromazine; Imipramine; Papaverine; Promethazine; Research; Succinylcholine | 1963 |
Rapid LC-MS/MS method for determination of drotaverine in a bioequivalence study.
Topics: Chromatography, Liquid; Humans; Imipramine; Methanol; Papaverine; Plasma; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency | 2014 |